19103727

Source:http://linkedlifedata.com/resource/pubmed/id/19103727

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205390, umls-concept:C0205396, umls-concept:C0557351, umls-concept:C0870077, umls-concept:C0871261, umls-concept:C1521828, umls-concept:C1546466, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	4
pubmed:dateCreated	2009-2-2
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19103727-18669457
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1527-7755
pubmed:author	pubmed-author:AndersonJames RJR, pubmed-author:KrailoMark DMD
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	27
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	646-7; author reply 647
pubmed:meshHeading	pubmed-meshheading:19103727-Clinical Trials, Phase II as Topic, pubmed-meshheading:19103727-Humans, pubmed-meshheading:19103727-Models, Theoretical, pubmed-meshheading:19103727-Research Design
pubmed:year	2009
pubmed:articleTitle	Problems identified with phase II stopping rules that employ response and early-progression rates.
pubmed:publicationType	Letter, Comment